TrialEBioMedicine2020

Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.

William Camu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.